Novel Method for Mass Production of Recombinant Proteins Using MSG
On 30th May, 2024, researchers at the Indian Institute of Science (IISc) unveiled a novel method to mass produce recombinant proteins, including vaccine antigens and insulin, replacing hazardous methanol with mono-sodium glutamate (MSG).
- The new expression system aims to produce proteins for biotech industries, including milk and egg proteins, baby food supplements, nutraceuticals, and therapeutic molecules.
- An Indian patent has been granted, and a US patent has been filed for the novel expression system, with plans to collaborate with industry partners for scaling up production.
- The conventional method involves using methanol to activate yeast cells, which poses significant safety risks due to its ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 IISc Develops Light-Charged Supercapacitor Technology
- 2 New Nanomaterial Tackles Heavy Metal Contamination
- 3 INCOIS Unveils ‘Integrated Ocean Energy Atlas’
- 4 IISc Develops Brain-Like AI Computing Platform
- 5 India Launches Three Indigenous Supercomputers
- 6 Indigenous Light Tank 'Zorawar'
- 7 ABHED: India’s Cutting-Edge Bulletproof Jacket
- 8 India’s Venus Orbiter Mission
- 9 Thermal Imaging Operations by ISRO’s EOS-08 Satellite
- 10 2024 PT5: A Temporary “Mini-Moon” of Earth
- 1 ISRO and CNES Collaborate on TRISHNA Mission
- 2 ISRO Develops “PraVaHa” CFD Software
- 3 NASA to Expand Collaboration with India
- 4 RudraM-II Missile
- 5 Chlorella Growth Factor (CGF)
- 6 New AI Model Predicts El Niño and La Niña 15 Months in Advance
- 7 Quantum Diamond Microchip Imager
- 8 Indian Army and IOCL Partner for Green Transport Solutions
